Enabling access to sarcoma trials in Quebec ($3.5M)

“With patients dispersed across the province, no single hospital could enroll enough patients to make a clinical trial viable. Patients had to travel far out-of-province or to the US. With your support, patients can now access trials here in Montréal, enabling us to advance research and grant patients potential avenues to prolonged, healthier lives.”

Dr. Ramy Saleh
Medical Director, Oncology Clinical Trials, RI-MUHC
Staff Medical Oncologist, MUHC

Dr. Robert Turcotte, an orthopedic surgeon, is part of the Orthopedic Oncology team at the MUHC and part of the McGill Sarcoma team.

Sarcomas are a rare, complex, and deadly group of cancers that arise in bones and connective tissues. 300 patients receive a diagnosis each year in Québec. Dr. Ramy Saleh co-founded and leads the Sarcoma Research Consortium of Quebec (SARC-Q), a consortium that currently consists of sarcoma experts from 12 hospitals, which aims to standardize sarcoma care across the province and consolidate all clinical trials at the MUHC.